Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.

RPEP-003901996RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.
Published In:
The Journal of clinical endocrinology and metabolism, 81(3), 1189-96 (1996)
Database ID:
RPEP-00390

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-00390·https://rethinkpeptides.com/research/RPEP-00390

APA

Thorner, M; Rochiccioli, P; Colle, M; Lanes, R; Grunt, J; Galazka, A; Landy, H; Eengrand, P; Shah, S. (1996). Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.. The Journal of clinical endocrinology and metabolism, 81(3), 1189-96.

MLA

Thorner, M, et al. "Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.." The Journal of clinical endocrinology and metabolism, 1996.

RethinkPeptides

RethinkPeptides Research Database. "Once daily subcutaneous growth hormone-releasing hormone the..." RPEP-00390. Retrieved from https://rethinkpeptides.com/research/thorner-1996-once-daily-subcutaneous-growth

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.